Oaktree Acquisition Corp. III Life Sciences (OACC) EPS (Basic) (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACC) quarterly EPS (Basic) came in at $0.07 in Q1 2026, down 15.96% YoY from $0.09 in Q1 2025, and down 22.07% on a QoQ basis from $0.09 in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACC) EPS (Basic) (2025 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACC) has 2 years of EPS (Basic) data on file, last reported at $0.07 in Q1 2026.
- Quarterly EPS (Basic) fell 15.96% year-over-year to $0.07 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.37 (changed N/A YoY) and the FY2025 annual result came in at $0.38, up 107.97% from the prior year.
- EPS (Basic) eased to $0.07 in Q1 2026, from $0.09 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.1 in Q3 2025 to a low of $0.07 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 0.07 |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 0.07 |
| 3 | Drugs Made In America Acquisition | 506.00 Mn | 506.00 Mn | - | 0.07 |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 0.07 |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 0.01 |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 0.09 |
| 7 | Pioneer Acquisition I | 390.89 Mn | 653.32 Mn | - | -0.01 |
| 8 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 0.07 |
| 9 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 0.05 |
| 10 | Oaktree Acquisition Corp. III Life Sciences | 206.39 Mn | 206.39 Mn | - | 0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.08 |
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.10 |
| Jun 30, 2025 | 0.10 |
| Mar 31, 2025 | 0.09 |